期刊文献+

联合应用氨溴索和异丙托溴铵对老年肺癌患者肺叶切除术后肺功能的影响 被引量:11

Effect of perioperative treatment with ambroxol combined with ipratropium on pulmonary function in elderly patients with lung cancer undergoing lobectomy
原文传递
导出
摘要 目的探讨围手术期应用氨溴索联合异丙托溴铵雾化吸入对老年肺癌患者肺叶切除术后肺功能的影响。方法行肺叶切除术的老年肺癌患者120例随机均分为两组,在常规治疗的基础上,术前1周至术后1周每天分别给予盐酸氨溴索静脉滴注加异丙托溴铵雾化吸入(治疗组)或等容量生理盐水(对照组)。比较两组手术前后肺功能和血气分析变化,记录术后肺部并发症、ICU入住率、术后住院时间和总住院费用。结果两组患者术后第1秒用力呼气容积、用力肺活量、呼气峰值流速、动脉血氧分压和氧合指数均较术前下降(P<0.05),对照组下降幅度更大(P<0.05)。治疗组术后ICU入住率、住院时间和总住院费用均低于对照组(P<0.01)。与对照组比较,治疗组肺部并发症发生率低(P<0.01)。结论围手术期静脉滴注氨溴索加异丙托溴铵雾化吸入能有效改善老年肺癌患者术后肺功能,减少呼吸系统并发症发生,缩短住院时间,降低住院费用。 Objective To evaluate the influence of perioperative treatment with ambroxol combined with ipratropium on pulmonary function in the elderly with lung cancer undergoing lobectomy.Methods One hundred and twenty elderly patients undergoing lobectomy for lung cancer were randomly assigned into two groups with 60 cases each.During one week before operation to one week after surgery,the patients in group A were infused ambroxol 150 mg intravenously twice a day and atomizing inhalation of ipratropium 6 ml in normal saline 2 ml for 15 minutes twice a day.The patients in group B were given equal volume of normal saline instead of ambroxol and ipratropium as the controls.The pulmonary function tests and arterial blood gas analysis were compared between two groups.The incidence of postoperative pulmonary complications,enterance rate of ICU,postoperative hospital stay and total costs of hospital stay were recorded.Results The forced expiratory volume in 1 second,forced vital capacity,peak expiratory flow rate,PaO2 and oxygen index were significantly lowered on the 7 th day after operation compared to those before surgery in both groups(P〈0.05),which were more in group B than those in group A.The postoperative enterance rate of ICU,hospital stay and total medical costs were all less in group A than those in group B(P〈0.05).The incidence of postoperative pulmonary complications was lower in group A than that in group B(P〈0.01).Conclusion Perioperative administration of ambroxol and ipratropium can effectively improve the postoperative lung function,reduce the pulmonary complications,shorten the postoperative hospital stay,and lower the total medical costs in the elderly with lung cancer undergoing lobectomy.
出处 《江苏医药》 CAS 2017年第24期1764-1766,共3页 Jiangsu Medical Journal
基金 国家"十一五"重大科技支撑计划(2008BAI0B05) 国家自然科学基金(81070074-H0116)
关键词 氨溴索 异丙托溴铵 肺叶切除术 肺癌 老年 Ambroxol Ipratropium Lobectomy Lung cancer Geriatrics
  • 相关文献

参考文献5

二级参考文献33

  • 1Hausen B, Bahra M, Mueller P, et al. Donor pretreatment with ambroxol or dexamethasone fails to ameliorate reperfusion injury in experimental lung transplantation. Transpl Int, 1998, 11 (3): 186 - 194.
  • 2Hong JS, Ko HH, Han ES, et al. Inhibition of bleomycin - induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxol. Biochem Pharmacol, 2003, 66 (7): 1297 - 1306.
  • 3Kim YK, Jang YY, Han ES, et al. Depressant effect of ambroxol on stimulated function responses and cell death in rat alveolar macrophages exposed to silica in vitro. J Pharmacol Exp Ther, 2002, 300(2) :629 -637.
  • 4Koyama J, Matsunaga T, Harada T, et al. Ambroxol reduces LPS toxicity mediated by induction of alkaline phosphatases in rat lung. Clin Biochem, 2004, 37 ( 8 ) :688 - 693.
  • 5Ottonello L, Arduino N, Bertolotto M, et al. In vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism. Br J Pharmacol, 2003, 140(4) : 736 -742.
  • 6Su X, Wang L, Song Y, et al. Inhibition of inflammatory responses by ambroxol, a mucolyte agent, in a murine model of acute lung injury induced by lipopolysaccharide. Intensive Care Med, 2004, 30(1) :133 -140.
  • 7Abraham D, Hofbauer R, Schafer R, et al. Selective down - regulation of VEGF - A( 165 ), VEGF - R( 1 ), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res, 2000, 87(8) :644 -647.
  • 8Abraham D, Krenn K, Seebacher G, et al. Upregulated hypoxia - Inducible factor - 1 DNA binding activity to the vascular endothelial growth factor - A promoter mediates increased vascular permeability in donorlung grafts. Ann Thorac Surg, 2004, 77 (5) :1751 - 1755.
  • 9Abraham D, Taghavi S, Rind P, et al. VEGF - A and - C but not - B mediate increased vascular permeability in preserved lung grafts. Transplantation, 2002, 73( 11 ) :1703 - 1706.
  • 10Larson J, Schomberg S, Schroeder W, et al. Endothelial EphA receptor stimulation increases lung vascular permeability. Am J Physiol Lung Cell Mol Physiol, 2008, 295 ( 3 ) : L431 - 439.

共引文献51

同被引文献97

引证文献11

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部